Clinicians are generally familiar with the side effects of most prescribed medications. However, the safety of newer medications such as golimumab, an anti-TNF drug to treat autoimmune disorders, is still being examined.

Rheumatoid arthritis and psoriatic arthritis share many characteristics. While a certain class of medications — called anti-TNFs — has been shown to be a helpful treatment for rheumatoid arthritis, it remains unclear how well they work for patients with psoriatic arthritis.